reports
Compass Lexecon Ranked Top Economic Consulting Firm on Lexology Index ...
Compass Lexecon Ranked Top Economic Consulting Firm on Lexology Index Competition 2025 List WASHINGTON, Aug. 13, 2025 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced that professionals from its Compass Lexecon subsidiary topped the Lexology Index: Competition 2025 list for global economic consulting firms, with 66 professionals named. In addition, six FTI Consulting professionals were named to the list. The following Compass Lexecon and FTI Consulting experts were also recognized as Global Elite Thought Leaders, a distinction reserved for professionals considered to ...
FTI Consulting Announces CFO Transition
FTI Consulting Announces CFO Transition WASHINGTON, Aug. 12, 2025 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced that its Chief Financial Officer, , will leave the Company on September 12, 2025, to accept a position outside of the consulting industry. FTI Consulting intends to appoint , FTI Consulting’s Chief Strategy and Transformation Officer, as interim Chief Financial Officer while the Company conducts a search for a permanent replacement. , CEO and Chairman of FTI Consulting, said, “On behalf of our Board of Directors and our leadership team, I would like t...
Matthews International Reports Results for Fiscal 2025 Third Quarter
Matthews International Reports Results for Fiscal 2025 Third Quarter Fiscal 2025 Third Quarter Financial Highlights: GAAP Earnings per share of $0.49 vs. $0.06 a year agoMemorialization and Industrial Technologies report higher adjusted EBITDAOutstanding debt reduced by $120 millionCompany realizing benefits of cost reduction actionsStrategic alternatives evaluation progressing wellCompany maintains outlook for fiscal 2025Webcast: Wednesday, August 6, 2025, 9:00 a.m., (201) 689-8471 PITTSBURGH, Aug. 05, 2025 (GLOBE NEWSWIRE) -- (NASDAQ GSM: MATW) today announced financial results f...
FTI Consulting Expands Forensic and Litigation Consulting Segment in A...
FTI Consulting Expands Forensic and Litigation Consulting Segment in Asia with Appointment of Martin Tupila as Senior Managing Director SINGAPORE, Aug. 04, 2025 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced the continued growth of its Forensic and Litigation Consulting segment in Asia with the appointment of as a Senior Managing Director, based in Singapore. Mr. Tupila brings more than 20 years of experience in forensic accounting, financial investigations, regulatory enforcement and compliance advisory across Asia, Europe and Australia. He has supported multinati...
- Blair Levin
SATS v. Carr: Post Earnings Call State of Play
Last Friday, SATS held its earnings. Our New Street colleagues offered their thoughts on the financial implications of what was learned (LINK). In this note, we analyze what the call revealed in terms of the state of play of the ongoing negotiations between FCC Chair Carr and SATS.
- Jonathan Moreland
ANTM ANTHEM INC.
SSB SOUTH STATE CORPORATION
SNV SYNOVUS FINANCIAL CORP.
SIGI SELECTIVE INSURANCE GROUP INC.
SFNC SIMMONS FIRST NATIONAL CORPORATION CLASS A
RLI RLI CORP.
PSX PHILLIPS 66
PRGS PROGRESS SOFTWARE CORPORATION
PNFP PINNACLE FINANCIAL PARTNERS INC.
NVCR NOVOCURE LTD.
MTH MERITAGE HOMES CORPORATION
MSCI MSCI INC. CLASS A
MOFG MIDWESTONE FINANCIAL GROUP
FBIZ FIRST BUSINESS FINANCIAL SERVICES
CNC CENTENE CORPORATION
CHTR CHARTER COMMUNICATIONS INC. CLASS A
ALGN ALIGN TECHNOLOGY INC.
UPS UNITED PARCEL SERVICE INC. CLASS B
PETS PETMED EXPRESS INC.
EPD ENTERPRISE PRODUCTS PARTNERS L.P.
PBT PERMIAN BASIN ROYALTY TRUST
LIND LINDBLAD EXPEDITIONS HOLDINGS
KYN KAYNE ANDERSON MLP INVESTMENT CO.
PLBC PLUMAS BANCORP
CZWI CITIZENS COMMUNITY BANCORP
MBIN MERCHANTS BANCORP
PGC PEAPACK-GLADSTONE FINANCIAL CORP.
LOOP LOOP INDUSTRIES
CHMG CHEMUNG FINANCIAL CORP.
FVCB FVCBANKCORP
TLRY TILRAY
TROX TRONOX HOLDINGS PLC
AMTB AMERANT BANCORP (A)
PCB PACIFIC CITY FINANCIAL CORP
DMAC DIAMEDICA THERAPEUTICS INC.
CRDF CARDIFF ONCOLOGY INC
ABSI ABSCI CORP
NSPR INSPIREMD INC
BRCC BRC INC
JMSB JOHN MARSHALL BANCORP INC
PRME PRIME MEDICINE INC
MMC MARSH & MCLENNAN COMPANIES INC.
STRW STRAWBERRY FIELDS REIT INC.
AURX NUO THERAPEUTICS
DMA INC.
MRAI DESTRA MULTI ALTERNATIVE FUND
GF MARPAI
CVM INC.
THE NEW GERMANY FUND
INC.
CEL-SCI CORPORATION
- Philip Burnett
SATS: Quick thoughts following the 2Q25 Call
In our note this morning, we flagged that on the call management was likely to stick to boilerplate language about continuing to work to stand up a successful fourth wireless network, and wouldn’t have much to say about the FCC negotiations. That was pretty much the case. However, we did learn interesting details on how the company is thinking about the D2D opportunity, and gained insights on recent activity in the wireless market. We cover thoughts on both in this brief note.
- Philip Burnett
SATS 2Q25 Quick Take: Slightly soft results; no spectrum updates, but ...
Financial results were generally a bit worse than expected, though part of the weakness stemmed from the cost of producing much better adds in wireless. Free cash flow missed consensus by a mile, but we suspect investors engaged on EchoStar were braced for estimates closer to ours.
- Wedbush Research
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
WDC WESTERN DIGITAL CORPORATION
VYGR VOYAGER THERAPEUTICS INC.
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
RARE ULTRAGENYX PHARMACEUTICAL INC.
PSTG PURE STORAGE INC. CLASS A
NVDA NVIDIA CORPORATION
NVCR NOVOCURE LTD.
NTAP NETAPP INC.
NBIX NEUROCRINE BIOSCIENCES INC.
MU MICRON TECHNOLOGY INC.
KURA KURA ONCOLOGY INC.
INTC INTEL CORPORATION
HURN HURON CONSULTING GROUP INC.
GME GAMESTOP CORP. CLASS A
GERN GERON CORP.
FATE FATE THERAPEUTICS INC
CTMX CYTOMX THERAPEUTICS INC.
BZH BEAZER HOMES USA INC.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
AXTI AXT INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ARDX ARDELYX INC
CDR CD PROJEKT S.A.
INOD INNODATA
FRX_CN FENNEC PHARMACEUTICALS
7974 NINTENDO CO. LTD.
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
EA ELECTRONIC ARTS INC.
CVCO CAVCO INDUSTRIES INC.
ANAB ANAPTYSBIO INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
ROKU ROKU INC. CLASS A
ISR ISORAY
AMZN AMAZON.COM INC.
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
IBM INTERNATIONAL BUSINESS MACHINES CORPORATION
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
REPL REPLIMUNE GROUP
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
UBER UBER TECHNOLOGIES INC.
STOK STOKE THERAPEUTICS
IGMS IGM BIOSCIENCES
IDYA IDEAYA BIOSCIENCES
PASG PASSAGE BIO
BDTX BLACK DIAMOND THERAPEUTICS
ACET ADICET BIO INC
KROS KEROS THERAPEUTICS
ITOS ITEOS THERAPEUTICS
ZNTL ZENTALIS PHARMACEUTICALS
LRMR LARIMAR THERAPEUTICS INC
PRAX PRAXIS PRECISION MEDICINES
U UNITY SOFTWARE
TVTX TRAVERE THERAPEUTICS INC
PLTR PALANTIR TECHNOLOGIES
VRDN VIRIDIAN THERAPEUTICS INC
IMNM IMMUNOME
PLTK PLAYTIKA HOLDING
RBLX ROBLOX
DAWN DAY ONE BIOPHARMACEUTICALS INC
STX SEAGATE TECHNOLOGY HLDGS PLC
ATXS ASTRIA THERAPEUTICS INC
GFS GLOBALFOUNDRIES INC
GMTX GEMINI THERAPEUTICS INC
VIGL VIGIL NEUROSCIENCE INC
TYRA TYRA BIOSCIENCES INC
EWTX EDGEWISE THERAPEUTICS INC
DDI DOUBLEDOWN INTERACTIVE CO LTD
APGE APOGEE THERAPEUTICS INC
SKLZ SKILLZ INC
EMBRAC B EMBRACER GROUP AB
DNTH DIANTHUS THERAPEUTICS INC
TLX TELIX PHARMACEUTICALS LIMITED
MAZE MAZE THERAPEUTICS INC
- David Nierengarten
- Dennis Pak
- Geoffrey Von Der Ahe
- Laura Chico
- Martin Fan
- Ritika Das
- Robert Driscoll
- Yun Zhong
XENE XENON PHARMACEUTICALS INC
VYGR VOYAGER THERAPEUTICS INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
NVCR NOVOCURE LTD.
NBIX NEUROCRINE BIOSCIENCES INC.
KURA KURA ONCOLOGY INC.
GERN GERON CORP.
FATE FATE THERAPEUTICS INC
CTMX CYTOMX THERAPEUTICS INC.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ARDX ARDELYX INC
FRX_CN FENNEC PHARMACEUTICALS
ANAB ANAPTYSBIO INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
ISR ISORAY
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SURF SURFACE ONCOLOGY
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
REPL REPLIMUNE GROUP
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
STOK STOKE THERAPEUTICS
IGMS IGM BIOSCIENCES
IDYA IDEAYA BIOSCIENCES
PASG PASSAGE BIO
BDTX BLACK DIAMOND THERAPEUTICS
ACET ADICET BIO INC
KROS KEROS THERAPEUTICS
ITOS ITEOS THERAPEUTICS
ZNTL ZENTALIS PHARMACEUTICALS
LRMR LARIMAR THERAPEUTICS INC
PRAX PRAXIS PRECISION MEDICINES
TVTX TRAVERE THERAPEUTICS INC
VRDN VIRIDIAN THERAPEUTICS INC
DAWN DAY ONE BIOPHARMACEUTICALS INC
ATXS ASTRIA THERAPEUTICS INC
GMTX GEMINI THERAPEUTICS INC
VIGL VIGIL NEUROSCIENCE INC
TYRA TYRA BIOSCIENCES INC
EWTX EDGEWISE THERAPEUTICS INC
APGE APOGEE THERAPEUTICS INC
DNTH DIANTHUS THERAPEUTICS INC
TLX TELIX PHARMACEUTICALS LIMITED
MAZE MAZE THERAPEUTICS INC
- Philip Burnett
SATS: The Only Thing That Matters Tomorrow
In its 8-K yesterday, EchoStar used vague language that could suggest it is open to selling some of its spectrum while continuing to try to build a business with the rest. When the company reports results tomorrow, investors will be singularly focused on any more concrete clues as to the company's intentions with its spectrum portfolio.
- Blair Levin
SATS and Carr: Is there really a best and final offer on the table?
As our New Street Colleagues discussed in a note yesterday afternoon, Bloomberg is reporting that the Chairman of the FCC has made a "best and final" offer to EchoStar that would force the company to sell its AWS-4 spectrum. Our colleagues focused on the economics of such a sale. In this note, we discuss the policy issues that we think are shaping those discussions and why we are skeptical that there is a “best and final” offer on the table.
- Jonathan Moreland
FTI Consulting Names Pat McLay as Leader of Accounting Advisory Practi...
FTI Consulting Names Pat McLay as Leader of Accounting Advisory Practice in Australia SYDNEY, July 30, 2025 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of as a Senior Managing Director and Australia Leader of the Accounting Advisory practice within the firm’s Forensic and Litigation Consulting segment. Mr. McLay, who is based in Melbourne, joins with more than 30 years of experience helping clients in Australia and the United Kingdom with accounting, external audit, consulting, transaction and internal audit services. He has advised clients in nu...
Novocure Ltd: 1 director
A director at Novocure Ltd bought 20,000 shares at 11.590USD and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...
- Philip Burnett
Matthews International Declares Quarterly Dividend
Matthews International Declares Quarterly Dividend PITTSBURGH, July 30, 2025 (GLOBE NEWSWIRE) -- (NASDAQ GSM: MATW) announced that its Board of Directors declared, at its regularly scheduled meeting today, a dividend of $0.25 per share on the Company’s common stock. The dividend is payable August 25, 2025 to stockholders of record August 11, 2025. About Matthews International CorporationMatthews International Corporation is a global provider of memorialization products, industrial Matthews International Corporation operates through two core global businesses – Industrial Technologies a...
- Philip Burnett
DBS Makes Interest Payments
Earlier this week, we flagged that the next piece of news from EchoStar would be about whether DBS was making interest payments that were originally due on July 1st. This morning, the company filed an 8-K stating that it has made the payments, thereby avoiding an "event of default".
Digital Transformation Expert Sabine Bennett Joins FTI Consulting’s He...
Digital Transformation Expert Sabine Bennett Joins FTI Consulting’s Healthcare & Human Services Practice in Australia SYDNEY, July 28, 2025 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of as a Senior Managing Director in the Australian Healthcare & Human Services practice. Ms. Bennett, who is based in Sydney, has more than 16 years of experience delivering large, complex, technology-enabled transformation programs for health, aged care and life sciences clients. In her role at FTI Consulting, she will bring her deep sector expertise to help cl...
- Philip Burnett
FCC Chair Flags Ongoing Discussions with EchoStar About Spectrum
On Friday FCC Chairman Brendan Carr was interviewed on CNBC about the Paramount merger. However, near the end of the discussion (around the 7:35 mark), he mentioned that he is having "ongoing discussions" with Charlie Ergen about putting EchoStar's spectrum to its "highest and best use." This answers the most common question we have been getting from clients over the last few weeks on the company, which is whether progress toward a settlement between the FCC and EchoStar is being made. Moreover,...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.